Residence of a firm and advance ruling limits: control in India and incomplete facts barred consideration of the tax questions.
A firm situated in India is treated as non-resident only if its control and management are wholly outside India; de facto control and management, not a merely formal right to control, determines residence. On the facts stated, day-to-day management remained with the resident partner in India, so the firm could not be regarded as non-resident. Questions on deduction under section 80-IC and processing charges were not answered because the outsourcing arrangement and the nature of the direct business were insufficiently disclosed. A ruling on the exemption position of a resident company was held to be outside advance ruling jurisdiction.
Issues: (i) Whether the applicant's firm could be treated as a non-resident firm for purposes of the Act having regard to the location of control and management of its affairs. (ii) Whether the questions relating to deduction under section 80-IC on direct business and processing charges could be answered on the facts placed before the Authority. (iii) Whether the question concerning exemption in the hands of Bayer Health, a resident company, fell within the scope of advance rulings jurisdiction.
Issue (i): Whether the applicant's firm could be treated as a non-resident firm for purposes of the Act having regard to the location of control and management of its affairs.
Analysis: The partnership deed showed that although policy decisions were reserved to the non-resident partner, the day-to-day business was to be handled by the resident partner in India. For a firm situated in India to qualify as non-resident, its control and management must be situated wholly outside India. The expression "control and management" refers to de facto control and management, not merely a formal right to control.
Conclusion: The firm could not be treated as a non-resident entity, and the application failed on this ground.
Issue (ii): Whether the questions relating to deduction under section 80-IC on direct business and processing charges could be answered on the facts placed before the Authority.
Analysis: The nature of the proposed direct business was not specified with sufficient clarity, and the terms and conditions governing the outsourcing arrangement with Bayer Health were also not placed on record. In the absence of complete facts, the questions could not be decided in a hypothetical manner.
Conclusion: These questions were not answerable on the material placed before the Authority.
Issue (iii): Whether the question concerning exemption in the hands of Bayer Health, a resident company, fell within the scope of advance rulings jurisdiction.
Analysis: The question related to the tax liability and exemption position of a resident company, which was outside the ambit of the advance ruling mechanism under Chapter XIX-B.
Conclusion: The question was beyond the Authority's jurisdiction.
Final Conclusion: The applicant failed to establish maintainability and the remaining questions were either inadequately supported by facts or outside the advance ruling jurisdiction, so the application could not be entertained.
Ratio Decidendi: A firm situated in India is resident unless its control and management are situated wholly outside India, and advance ruling jurisdiction cannot be used to decide hypothetical or inadequately pleaded questions or the tax liability of a person outside its statutory scope.
TaxTMI 
AI Drafter ✕
TaxTMI 
